Form 4: Arteris Inc. Director Acquires Stock

Arteris, Inc. Director Joachim Kunkel acquired 899 shares of common stock as retainer fees, valued at $15.98 per share.

Summary

• Joachim Kunkel, a Director at Arteris, Inc., acquired 899 shares of common stock on April 5, 2026.
• These shares were received as retainer fees in lieu of cash, based on an average stock price of $15.98.
• The transaction was made pursuant to a written plan intended to satisfy Rule 10b5-1(c) affirmative defense conditions.
• Following this transaction, Kunkel beneficially owns 69,627 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard insider stock acquisition for compensation purposes under a pre-arranged plan, with no immediate indication of significant positive or negative market impact.

Positives

• Director Kunkel's acquisition of shares indicates continued commitment and alignment with the company's performance.
• The transaction was executed under a Rule 10b5-1(c) plan, suggesting a pre-determined and structured approach to stock transactions.
• The shares were acquired as retainer fees, implying that the company is compensating its directors, which is a standard practice.

Future Outlook

No specific forward-looking statements or guidance were provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. This specific filing details a routine compensation-related stock acquisition by a director.

Key Dates

Keywords

Arteris Inc., Form 4, Director, Stock Acquisition, Beneficial Ownership, Securities Exchange Act, Rule 10b5-1(c)